Analystreport

Mirati Therapeutics, Inc. (NASDAQ: MRTX) was upgraded by analysts at BidaskClub from a "buy" rating to a "strong-buy" rating.

Mirati Therapeutics, Inc.  (MRTX) 
Last mirati therapeutics, inc. earnings: 2/25 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.mirati.com/node/5806